View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0935-0260
ICR Reference No:
202209-0935-004
Status:
Historical Active
Previous ICR Reference No:
202107-0935-003
Agency/Subagency:
HHS/AHRQ
Agency Tracking No:
Title:
The AHRQ Safety Program for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
11/22/2022
Retrieve Notice of Action (NOA)
Date Received in OIRA:
10/19/2022
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
11/30/2025
36 Months From Approved
08/31/2024
Responses
36,928
0
36,637
Time Burden (Hours)
12,052
0
11,552
Cost Burden (Dollars)
0
0
0
Abstract:
The Agency for Healthcare Research and Quality (AHRQ) requests to revise the currently approved AHRQ Safety Program for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention. The AHRQ Safety Program for MRSA Prevention’s purpose is to reduce the incidence and prevalence of infections caused by MRSA in a variety of settings. The revision for the AHRQ Safety Program for MRSA Prevention includes the following modifications: 1. ICU/Non-ICU cohort: The optional point prevalence data will be collected at baseline (pre-intervention) and every six months throughout the 18-month implementation period rather than only at baseline. 2. Surgical Services cohort: After a discussion with the program’s Technical Expert Panel (TEP), it was decided to collect surgical site infection (SSI) outcome data on a different subset of surgical procedures performed within the cardiac surgery, orthopedic surgery, and neurosurgery specialty areas. 3. Long-Term Care (LTC) cohort: The LTC cohort will now also submit the Minimum Data Set (MDS) 3.0 M Skin Conditions data elements.
Authorizing Statute(s):
US Code:
42 USC 299
Name of Law: Agency for Healthcare Research and Quality Act of 1999
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
87 FR 43521
07/21/2022
30-day Notice:
Federal Register Citation:
Citation Date:
87 FR 61323
10/09/2022
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
15
IC Title
Form No.
Form Name
Attachment H: Survey of Patient Safety Culture – HSOPS
1
Attachment H: Survey of Patient Safety Culture – HSOPS
Attachment I: Survey of Patient Safety Culture – NHSOPS
2
2,500
Attachment J - Subsequent data pull for 10% of units
9.5
Attachment J - Subsequent data pull for 10% of units
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
9
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
9
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
9
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
9
Attachment J: Clinical Outcomes Data for ICU/Non-ICU
Attachment K: Clinical Outcomes Data for Surgical Services
10
Attachment K: Clinical Outcomes Data for Surgical Services
Attachment K: Clinical Outcomes Data for Surgical Services
10
Attachment K: Clinical Outcomes Data for Surgical Services
Attachment L: Clinical Outcomes Data for LTC
11
Attachment L: Clinical Outcomes Data for LTC
Attachment L: Clinical Outcomes Data for LTC
11
Attachment L: Clinical Outcomes Data for LTC
Attachment Q: Survey of Patient Safety Culture-HSOPS V.2
17
Attachment Q: Survey of Patient Safety Culture—HSOPS V.2
Gap Analysis
3, 4, 5
Attachment B: ICU/Non-ICU Gap Analysis
,
Attachment C: Surgical Services Gap Analysis
,
Attachment D: LTC Gap Analysis
TEAM CHECK-UP TOOL – Long-Term Care (LTC)
8
Attachment G: LTC Team Checkup Tool
Team Checkup Tool
6, 7
Attachment E: ICU/Non-ICU Team Checkup Tool
,
Attachment F: Surgical Services Team Checkup Tool
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
36,928
36,637
0
291
0
0
Annual Time Burden (Hours)
12,052
11,552
0
500
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Miscellaneous Actions
Short Statement:
There is a reduction in burden from 15 minutes to 12.5 minutes per survey for the HSOPS 2.0 due to the shorter length of the instrument compared to Version 1.0.
Annual Cost to Federal Government:
$1,977,501
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Erwin Brown 301 427-1652 erwin.brown@ahrq.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
10/19/2022